Loading clinical trials...
Loading clinical trials...
A Phase 1b/2, Multi-Center, Double-Blind (Principal Investigators and Study Subjects Blinded, Sponsor Unblinded), Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Conditions
Interventions
DS-1040b
Placebo
Locations
55
United States
University of South Alabama USA Health System
Mobile, Alabama, United States
UCLA Medical Center Stroke Network
Los Angeles, California, United States
UC Health Memorial Hospital
Colorado Springs, Colorado, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
University of Louisville
Louisville, Kentucky, United States
Start Date
September 1, 2015
Primary Completion Date
August 13, 2019
Completion Date
August 13, 2019
Last Updated
September 9, 2020
NCT07253181
NCT06990867
NCT07001267
NCT03153683
NCT07371624
NCT05847699
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions